Alphaform AG (AFRMF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Alphaform AG (AFRMF) with AI Score 53/100 (Hold). Alphaform AG provides generative 3D layering technologies and manufactures medical products across Europe and the US. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 16, 2026Alphaform AG (AFRMF) Industrial Operations Profile
Alphaform AG specializes in 3D printing and advanced manufacturing solutions, serving diverse industries like automotive, aerospace, and medical technology. With a focus on prototyping and small series production, the company operates primarily in Europe and the United States, leveraging its expertise in AM plastics, metals, and precision casting.
Investment Thesis
Alphaform AG presents a focused play on the additive manufacturing sector, particularly in prototyping and small-series production. The company's gross margin of 64.7% indicates a strong pricing power and efficient operations. However, the negative profit margin of -10.3% raises concerns about overall profitability and cost management. Growth catalysts include expanding applications of 3D printing in medical technology and aerospace. Potential risks include intense competition and the company's negative beta of -6306.06, indicating high volatility or inverse correlation with the market. Investors should closely monitor the company's ability to achieve profitability and manage its operational expenses.
Based on FMP financials and quantitative analysis
Key Highlights
- Gross margin of 64.7% indicates strong pricing power in its niche market.
- Serves diverse industries including automotive, aerospace, and medical technology, reducing sector-specific risk.
- Focus on prototyping and small series production allows for specialized service offerings.
- Geographic presence in Europe, Turkey, and the United States provides international market access.
- Operates through three segments: AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting, offering a range of services.
Competitors & Peers
Strengths
- Specialized expertise in 3D printing and additive manufacturing.
- Diverse customer base across multiple industries.
- Established presence in Europe and the United States.
- Strong gross margin of 64.7%.
Weaknesses
- Negative profit margin of -10.3%.
- Limited brand recognition compared to larger competitors.
- High beta of -6306.06 indicates high volatility.
- Dependence on specific industries and geographic regions.
Catalysts
- Ongoing: Increasing adoption of 3D printing in medical technology and aerospace sectors.
- Ongoing: Strategic partnerships with universities and research institutions.
- Upcoming: Potential expansion into new geographic markets in Asia-Pacific (2027-2028).
- Ongoing: Development of new materials and processes for additive manufacturing.
- Ongoing: Growing demand for customized medical implants and devices.
Risks
- Potential: Intense competition from larger players in the 3D printing industry.
- Potential: Economic downturns affecting key customer industries.
- Potential: Technological advancements rendering existing technologies obsolete.
- Potential: Regulatory changes impacting medical device manufacturing.
- Ongoing: Limited financial disclosure and transparency due to OTC listing.
Growth Opportunities
- Expansion in Medical Technology: The increasing demand for customized medical implants and devices presents a significant growth opportunity for Alphaform AG. The market for 3D-printed medical devices is projected to reach $6 billion by 2028, offering substantial revenue potential. Alphaform AG's existing expertise in manufacturing hip joint implants and cranial trauma plates positions it well to capitalize on this trend. Timeline: Ongoing.
- Aerospace Industry Applications: The aerospace industry is increasingly adopting 3D printing for manufacturing lightweight components and complex geometries. Alphaform AG can leverage its AM Metal/Rapid Tooling segment to provide solutions for aerospace companies. The market for 3D-printed aerospace components is expected to reach $5 billion by 2027. Timeline: Ongoing.
- Automotive Prototyping and Tooling: The automotive industry relies heavily on prototyping and tooling for new vehicle development. Alphaform AG can expand its services in providing plastic and metal parts for automotive prototyping. The market for 3D-printed automotive components is projected to reach $4 billion by 2026. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic partnerships with universities and research institutions can provide Alphaform AG with access to cutting-edge technologies and research. Collaborations can lead to the development of new materials and processes, enhancing the company's competitive advantage. Timeline: Ongoing.
- Geographic Expansion: Expanding operations into new geographic markets, particularly in Asia-Pacific, can drive growth for Alphaform AG. The demand for 3D printing solutions is increasing rapidly in emerging economies. Timeline: Upcoming: 2027-2028.
Opportunities
- Expansion in medical technology and aerospace sectors.
- Strategic partnerships with universities and research institutions.
- Geographic expansion into emerging markets.
- Development of new materials and processes.
Threats
- Intense competition from larger players in the 3D printing industry.
- Economic downturns affecting key customer industries.
- Technological advancements rendering existing technologies obsolete.
- Regulatory changes impacting medical device manufacturing.
Competitive Advantages
- Specialized expertise in 3D printing and additive manufacturing.
- Strong relationships with customers in diverse industries.
- Proprietary technologies and processes in AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting.
- Established presence in Europe and the United States.
About AFRMF
Founded in 1995 and headquartered in Feldkirchen, Germany, Alphaform AG has evolved into a provider of generative 3D layering technologies and advanced manufacturing solutions. The company operates through three primary segments: AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting. Alphaform AG offers a comprehensive suite of services, including consulting on product development, manufacturing virtual and real prototypes, and producing small series of products. Its capabilities extend to creating prototype parts and models from rein and plastic powder, as well as plastic and metal parts for the automotive industry. Alphaform AG also manufactures medical implants, such as hip joint implants, cranial trauma plates, knee implants, and clips for tendon operations. The company serves a diverse range of sectors, including automotive, machinery, plant and commercial vehicle construction, aerospace and aviation, tool making, medical technology, household appliances, and telecommunications. Its customer base includes electro-technical companies, universities, and research institutions. Alphaform AG's geographic reach spans Germany, the rest of Europe, Turkey, and the United States.
What They Do
- Provides generative 3D layering technologies.
- Manufactures medical products.
- Offers consulting on product development processes.
- Manufactures virtual and real prototypes.
- Produces small series of products.
- Creates prototype parts and models from rein and plastic powder.
- Manufactures plastic and metal parts for the automotive industry.
- Provides medical implants such as hip joint implants and cranial trauma plates.
Business Model
- Provides consulting services for product development.
- Generates revenue through manufacturing prototypes and small series of products.
- Sells medical implants and related devices.
- Offers 3D printing and additive manufacturing services to various industries.
Industry Context
Alphaform AG operates within the industrial machinery sector, specifically focusing on additive manufacturing and 3D printing. The industry is experiencing rapid growth, driven by increasing adoption of 3D printing technologies across various sectors. The competitive landscape includes companies like APRO, CDIIQ, ESNC, HYHY, and JKSM, which offer similar services in prototyping and manufacturing. Alphaform AG's focus on specialized applications, such as medical implants, positions it within a niche market segment with potential for high growth and margins.
Key Customers
- Automotive industry
- Aerospace and aviation sector
- Medical technology companies
- Universities and research institutions
- Electro-technical companies
Financials
Chart & Info
Alphaform AG (AFRMF) stock price: Price data unavailable
Latest News
No recent news available for AFRMF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AFRMF.
Price Targets
Wall Street price target analysis for AFRMF.
MoonshotScore
What does this score mean?
The MoonshotScore rates AFRMF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Hanns-Dieter Aberle
Managing Director
Hanns-Dieter Aberle serves as the Managing Director of Alphaform AG, overseeing the company's operations and strategic direction. His background includes extensive experience in industrial manufacturing and technology management. Aberle has held various leadership positions in engineering and production, focusing on process optimization and innovation. He brings a wealth of knowledge in advanced manufacturing techniques and business development to Alphaform AG.
Track Record: Under Hanns-Dieter Aberle's leadership, Alphaform AG has focused on expanding its presence in the medical technology sector and strengthening its relationships with key customers. He has overseen the implementation of new technologies and processes to improve efficiency and reduce costs. Aberle has also emphasized the importance of innovation and strategic partnerships to drive growth and maintain a competitive edge in the market.
AFRMF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Alphaform AG may not meet the minimum financial or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and operational performance. Investing in OTC Other stocks carries higher risks due to the lack of regulatory oversight and transparency compared to stocks listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Potential for low trading volume and liquidity.
- Higher risk of price manipulation and volatility.
- Lack of regulatory oversight and investor protection.
- Increased risk of fraud or mismanagement.
- Verify the company's legal standing and registration.
- Obtain and review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Check for any regulatory actions or legal proceedings against the company.
- Established history of operations since 1995.
- Presence in multiple geographic regions, including Europe and the United States.
- Diverse customer base across various industries.
- Focus on specialized applications in medical technology and aerospace.
- Management team with experience in industrial manufacturing and technology management.
Common Questions About AFRMF
What does Alphaform AG do?
Alphaform AG specializes in providing generative 3D layering technologies and manufacturing medical products. The company operates through AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting segments, serving industries such as automotive, aerospace, and medical technology. Alphaform AG offers services including consulting on product development, manufacturing prototypes, and producing small series of products, with a focus on customized solutions and specialized applications.
What do analysts say about AFRMF stock?
As of 2026-03-16, there is no readily available analyst consensus on Alphaform AG (AFRMF) due to its OTC listing and limited coverage. Key valuation metrics such as P/E ratio are not meaningful due to negative earnings. Investors should focus on revenue growth, gross margin, and the company's ability to achieve profitability. Growth considerations include expanding applications in medical technology and aerospace, as well as strategic partnerships and geographic expansion.
What are the main risks for AFRMF?
The main risks for Alphaform AG include intense competition in the 3D printing industry, economic downturns affecting key customer industries, and technological advancements rendering existing technologies obsolete. Additionally, regulatory changes impacting medical device manufacturing and the limited financial disclosure due to its OTC listing pose significant risks. Investors should also consider the potential for low trading volume and liquidity, as well as the higher risk of price manipulation and volatility associated with OTC stocks.
What are the key factors to evaluate for AFRMF?
Alphaform AG (AFRMF) currently holds an AI score of 53/100, indicating moderate score. Key strength: Specialized expertise in 3D printing and additive manufacturing.. Primary risk to monitor: Potential: Intense competition from larger players in the 3D printing industry.. This is not financial advice.
How frequently does AFRMF data refresh on this page?
AFRMF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AFRMF's recent stock price performance?
Recent price movement in Alphaform AG (AFRMF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized expertise in 3D printing and additive manufacturing.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AFRMF overvalued or undervalued right now?
Determining whether Alphaform AG (AFRMF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AFRMF?
Before investing in Alphaform AG (AFRMF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited due to the company's OTC listing and lack of comprehensive reporting.
- Analyst coverage is minimal, making it difficult to assess market sentiment and valuation.